Continuum Advisory’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Continuum Advisory's JAZZ Position: Q2 2026 in Review
Continuum Advisory opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 55 shares worth $13.3K. The stake represents ﹤0.01% of the portfolio and ranks #1172 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in JAZZ as recently as Q1 2025.
Continuum Advisory first reported a position in JAZZ in Q1 2024 and has held it in 6 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Continuum Advisory held 55 shares of Jazz Pharmaceuticals worth $13.3K as of Q2 2026.
- Jazz Pharmaceuticals was a new Continuum Advisory position in Q2 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1172 holding.
- Continuum Advisory first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.